The Edora series of heart pacemakers was launched by Biotronik in Europe. The MR-conditional pacemakers, which are lighter and smaller than earlier models, come with cardiac resynchronization therapy, home monitoring settings and an MRI AutoDetect functionality that enables automatic adaptation of the system to an MRI environment.
The FDA has given Bovie Medical clearance for its J-Plasma generator and handpiece with Cool-Coag technology for surgical cutting and coagulation. The plasma-based device creates an ionized gas beam using a helium ionization process to improve precision, prevent conductive currents through the patient and provide minimal invasiveness, while the technology brings helium spray coagulation and standard monopolar coagulation capabilities together in one handpiece.
An additional Singapore patent has been secured by Orthocell for its Celgro Smart Graft, a collagen-based medical device designed for use in soft-tissue regeneration. The patent refers to the company's manufacturing method for novel bio-scaffolds that are intended for facilitating surgical treatment of soft-tissue injuries.
The Department of Defense has exercised the eighth one-year option, valued at $77.2 million, on a potential nine-year contract with Philips Healthcare to continue providing the Army, Air Force, Navy, Marine Corps and federal civilian agencies with patient monitoring devices, spare parts, accessories and training. The option period closes March 29, 2018.
A private placement has brought in $10.4 million for Mountain View, Calif.-based Vascular Dynamics, a maker of catheter-delivered technologies for treating resistant hypertension. The proceeds will be used to support studies of the company's MobiusHD system.
UK diagnostics company Owlstone Medical has secured an approximately $5 million investment from Aviva Ventures, the venture capital arm of insurance company Aviva. The company intends to use the money to support commercialization and adoption of its Breath Biopsy system.
A 1,684-patient trial presented at the annual American College of Cardiology Scientific Session showed positive results for Boston Scientific's Synergy bioresorbable-polymer drug-eluting stent. Use of the Synergy stent demonstrated noninferiority in target lesion failure at 12 months and a higher relative reduction of 85% in stent thrombosis beyond one to two years, compared with the Promus Element Plus drug-eluting stent.
The SurgiCount tablet, a 10-inch touch-screen tablet, has been released by Stryker for its SurgiCount safety sponge system, which uses unique identifiers to track and maintain a count of items used during surgery to prevent the occurrence of retained surgical items. The tablet enables real-time, fully encrypted transfer of data to secure cloud-based servers using Wi-Fi connectivity.
An application for CE IVD certification has been filed by molecular diagnostics company Genedrive for its Genedrive HCV ID Kit, an assay intended for decentralized hepatitis C testing. The qualitative molecular HCV test, which runs on the portable Genedrive platform, uses a small plasma sample to produce results in 90 minutes.
Johnson & Johnson's Janssen branch launched an online campaign for its psoriasis drug, Stelara, featuring "Scandal" actress Katie Lowes and other psoriasis advocates. The campaign is called "Psoriasis: The Inside Story" and will include blog posts and video discussions about living with psoriasis.